Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,515,931
+$12,414,570 QoQ
Shares Held
223,922
+1082.3% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Mar 31, 2026CallValue
$1,151,370
CallShares
19,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. XENE ranks #65 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in XENE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,515,931 | 223,922 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,151,370 | 19,800 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,101,361 | 18,940 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,382,741 | 30,851 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,945,468 | 48,455 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,437,807 | 141,783 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,105,907 | 152,188 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,409,341 | 86,973 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,066,598 | 204,892 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,305,540 | 161,722 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,546,544 | 198,526 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,876,087 | 84,153 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,385,085 | 40,547 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,801,682 | 98,745 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,396,790 | 206,672 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,211,400 | 360,421 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,785,224 | 409,563 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,933,407 | 326,542 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $10,104,210 | 330,527 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,843,373 | 475,140 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,274,871 | 148,879 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,055,001 | 164,071 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,132,410 | 174,995 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,825,920 | 183,740 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,128,904 | 192,313 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,628,608 | 209,618 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,616,040 | 142,508 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||